By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Ophthalmic steroids > Dexamethasone (ophthalmic) > Dexamethasone Ophthalmic Dosage
Ophthalmic steroids
https://themeditary.com/dosage-information/dexamethasone-ophthalmic-dosage-10201.html

Dexamethasone Ophthalmic Dosage

Drug Detail:Dexamethasone (ophthalmic) (Dexamethasone (ophthalmic) [ dex-a-meth-a-sone-off-thal-mik ])

Drug Class: Ophthalmic steroids

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Iritis

Suspension: Instill one or two drops topically in the conjunctival sac(s).

Comments:

  • In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation decreases.
  • In mild disease, drops may be used up to four to six times a day, being tapered to discontinuation as the inflammation decreases.

Ointment: Apply a one-half to one inch ribbon of ointment into the conjunctival sac(s) up to four times a day

Comments:
  • When improvement is observed, use may be reduced gradually to once a day application for several days.
  • Ointment may be used in conjunction with suspension.

Uses:
  • Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe (including allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivities, corneal injury from chemical or thermal burns, or penetration of foreign bodies)

Usual Adult Dose for Keratitis

Suspension: Instill one or two drops topically in the conjunctival sac(s).

Comments:

  • In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation decreases.
  • In mild disease, drops may be used up to four to six times a day, being tapered to discontinuation as the inflammation decreases.

Ointment: Apply a one-half to one inch ribbon of ointment into the conjunctival sac(s) up to four times a day

Comments:
  • When improvement is observed, use may be reduced gradually to once a day application for several days.
  • Ointment may be used in conjunction with suspension.

Uses:
  • Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe (including allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivities, corneal injury from chemical or thermal burns, or penetration of foreign bodies)

Usual Adult Dose for Conjunctivitis

Suspension: Instill one or two drops topically in the conjunctival sac(s).

Comments:

  • In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation decreases.
  • In mild disease, drops may be used up to four to six times a day, being tapered to discontinuation as the inflammation decreases.

Ointment: Apply a one-half to one inch ribbon of ointment into the conjunctival sac(s) up to four times a day

Comments:
  • When improvement is observed, use may be reduced gradually to once a day application for several days.
  • Ointment may be used in conjunction with suspension.

Uses:
  • Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe (including allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivities, corneal injury from chemical or thermal burns, or penetration of foreign bodies)

Usual Adult Dose for Cyclitis

Suspension: Instill one or two drops topically in the conjunctival sac(s).

Comments:

  • In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation decreases.
  • In mild disease, drops may be used up to four to six times a day, being tapered to discontinuation as the inflammation decreases.

Ointment: Apply a one-half to one inch ribbon of ointment into the conjunctival sac(s) up to four times a day

Comments:
  • When improvement is observed, use may be reduced gradually to once a day application for several days.
  • Ointment may be used in conjunction with suspension.

Uses:
  • Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe (including allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivities, corneal injury from chemical or thermal burns, or penetration of foreign bodies)

Usual Adult Dose for Uveitis

One implant, containing 0.7 mg of dexamethasone, to be surgically injected into the vitreous cavity of the affected eye

Comments:

  • Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis.

Uses: Treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO), non-infectious uveitis affecting the posterior segment of the eye, and diabetic macular edema

Usual Adult Dose for Macular Edema

One implant, containing 0.7 mg of dexamethasone, to be surgically injected into the vitreous cavity of the affected eye

Comments:

  • Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis.

Uses: Treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO), non-infectious uveitis affecting the posterior segment of the eye, and diabetic macular edema

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • The manufacturer product information should be consulted.

Monitoring:
  • Ocular: Elevation in intraocular pressure and endophthalmitis following intravitreal injection by checking for perfusion of the optic nerve head immediately after injection, tonometry within 30 minutes following injection, and biomicroscopy between two and seven days following injection.

Patient advice:
  • Patients may experience temporary visual burning after receiving an intravitreal injection and should not drive or use machinery until symptoms have been resolved.
  • Patients should be instructed to report any symptoms suggestive of endophthalmitis without delay.
  • Patients should be instructed not to touch the tip of the dropper or ointment directly to the eye.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by